Icon Plc (ICLR) 77.00 $ICLR How These Healthcare Stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Icon Plc (ICLR) 77.00 $ICLR

How These Healthcare Stocks are Performing? -- AMAG Pharma, IDEXX Laboratories, Neogenomics, and ICON
PR Newswire - Fri Jul 29, 7:50AM CDT
The Healthcare sector remains one of the most stable industries in the market, unfazed by economic conditions and uncertainties. While the industry faces issues with cost pressures, ransomware risks, and existing policies, several companies remain unscathed and continue to impress with significant returns. Stocks to evaluate today on Stock-Callers.com are AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), IDEXX Laboratories Inc. (NASDAQ: IDXX), Neogenomics Inc. (NASDAQ: NEO), and ICON PLC (NASDAQ: ICLR). Learn more about these stocks by accessing their free notes at:
NEO: 8.56 (+0.04), AMAG: 27.11 (+0.09), IDXX: 107.11 (+13.60), ICLR: 77.00 (+0.03)

SmarTrend Watching for Potential Pullback in Shares of ICON After 5.54% Gain
Comtex SmarTrend(R) - Tue Jul 26, 3:38PM CDT
ICON (NASDAQ:ICLR) traded in a range yesterday that spanned from a low of $72.70 to a high of $76.34. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high of $72.61 on volume of 724,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ICLR: 77.00 (+0.03)

ICON Reports Second Quarter 2016 Results
BusinessWire - Tue Jul 26, 5:00AM CDT
--Record net business wins of $502 million, a net book to bill of 1.22.
ICLR: 77.00 (+0.03)

SmarTrend Watching for Potential Pullback in Shares of ICON After 2.83% Gain
Comtex SmarTrend(R) - Wed Jun 22, 2:18PM CDT
ICON (NASDAQ:ICLR) traded in a range yesterday that spanned from a low of $65.14 to a high of $67.47. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $65.88 on volume of 339,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ICLR: 77.00 (+0.03)

ICON and Pfizer Extend Ties, Sign New Agreement
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:12AM CDT
ICON Plc (ICLR), recently signed a three-year service agreement with its existing customer Pfizer Inc. (PFE).
AIRM: 32.66 (-0.04), PFE: 36.43 (-0.88), AHS: 43.52 (+0.21), ICLR: 77.00 (+0.03)

New Research from ICON Demonstrates Support for 'Bring Your Own Device' Approach in Clinical Trials
BusinessWire - Wed Jun 15, 2:00AM CDT
ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced research showing many pharmaceutical and clinical research organisations (CROs) support the use of a 'Bring Your Own Device' (BYOD) approach in clinical studies, enabling patients to use their own mobile devices to collect patient-reported outcomes (PRO) data. The research highlights how commonly-cited concerns around the use of patients' own devices are not as much of a deterrent to adoption as is often thought.
ICLR: 77.00 (+0.03)

ICON Announces Service Agreement with Pfizer
BusinessWire - Fri Jun 10, 5:00AM CDT
ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced it has signed a three-year agreement with Pfizer Inc. (NYSEFE). Under the terms of the agreement, Pfizer has the right to extend the term for up to an additional two years. Financial details of the agreement were not disclosed.
PFE: 36.43 (-0.88), ICLR: 77.00 (+0.03)

Downgrade Alert for ICON (ICLR)
Comtex SmarTrend(R) - Thu Jun 09, 3:20AM CDT
ICON (NASDAQ:ICLR) was downgraded from Market Perform to Underperform at Avondale today. The stock closed yesterday at $69.90 on volume of 407,000 shares, below average daily volume of 447,000. There is potential upside of 14.8% for shares of ICON based on a current price of $69.90 and an average consensus analyst price target of $80.22. The stock should find initial resistance at its 50-day moving average (MA) of $71.69 and further resistance at its 200-day MA of $72.54.
ICLR: 77.00 (+0.03)

ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research Excellence Awards
BusinessWire - Mon May 16, 4:55AM CDT
ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that, together with Pfizer, it has won the Clinical Research Team of the Year award at the inaugural Clinical and Research Excellence (CARE) Awards which took place in Boston on the 27th April.
ICLR: 77.00 (+0.03)

ICON Set to Possibly Rebound After Yesterday's Selloff of 8.53%
Comtex SmarTrend(R) - Tue Apr 26, 3:47PM CDT
ICON (NASDAQ:ICLR) traded in a range yesterday that spanned from a low of $66.39 to a high of $72.06. Yesterday, the shares fell 8.5%, which took the trading range below the 3-day low of $71.27 on volume of 706,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ICLR: 77.00 (+0.03)

Icon PLC beats 1Q profit forecasts
Automated Insights - Tue Apr 26, 5:06AM CDT
DUBLIN 18, Ireland (AP) _ Icon PLC (ICLR) on Tuesday reported first-quarter net income of $63 million.
ICLR: 77.00 (+0.03)

ICON Reports First Quarter 2016 Results
BusinessWire - Tue Apr 26, 5:00AM CDT
--Backlog of business up 9% year on year to $3.95 billion
ICLR: 77.00 (+0.03)

Mr. Thomas Lynch Notifies ICON of His Retirement as Chairman and That He Will Not Stand for Re-Election to the Board of Directors at the Annual General Meeting
BusinessWire - Tue Mar 29, 5:00AM CDT
ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr. Thomas Lynch, non-executive chairman of the board of directors, has notified ICON that he will retire as chairman on 31 March 2016 and will not stand for re-election to the board at the company's annual general meeting in July 2016. Mr. Lynch has been a non-executive director of ICON since 1994 and served as senior independent director from 2010 to 2012 and as chairman since January 2013.
ICLR: 77.00 (+0.03)

4 Hot Stocks to Keep an Eye Out For in Medical Services
Zacks Equity Research - Zacks Investment Research - Tue Mar 22, 8:15AM CDT
A gradual transformation from providing volume to value-based-care model is underway, which is expected to bring in a revolutionary change in the healthcare service system.
PRXL: 67.09 (-0.32), PRAH: 47.12 (+0.04), ICLR: 77.00 (+0.03), CGIX: 2.00 (-0.03)

Envision Healthcare (EVHC) Set to Buy EPMG in Michigan
Zacks Equity Research - Zacks Investment Research - Fri Mar 18, 10:10AM CDT
Envision Healthcare Holdings Inc. (EVHC) is set to acquire Michigan-based Emergency Physicians Medical Group (EPMG) for approximately $120 million.
PRXL: 67.09 (-0.32), EVHC: 23.87 (+0.28), PRAH: 47.12 (+0.04), ICLR: 77.00 (+0.03)

ICON and ICHOM to Roll out GLOBE Benchmarking Program
Zacks Equity Research - Zacks Investment Research - Thu Mar 10, 10:20AM CST
ICON Public Limited Company (ICLR) recently announced that its data management, data analytics and consultancy capabilities have been selected by the International Consortium for Health Outcomes Measurement.
ABMD: 119.67 (+0.17), LMNX: 21.67 (-0.19), CRY: 14.23 (-0.09), ICLR: 77.00 (+0.03)

ICON Selected by the International Consortium for Health Outcomes Measurement to Help Advance Value-based Healthcare
BusinessWire - Tue Mar 08, 5:00AM CST
ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by the International Consortium for Health Outcomes Measurement (ICHOM) to advance value-based healthcare through the launch of a global healthcare outcomes benchmarking program called GLOBE. ICON is using its data management, data analytics and consultancy expertise to enable ICHOM to provide healthcare providers with a secure platform to share and compare high-quality, risk-adjusted health outcomes - the results of care that matter most to patients - that will lead to improvements in healthcare.
ICLR: 77.00 (+0.03)

ICON selected by Genomics England to support the largest genome sequencing project of its kind for cancer and rare diseases
BusinessWire - Tue Feb 09, 4:00AM CST
ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Genomics England as data management partner for the 100,000 Genomes Project.
ICLR: 77.00 (+0.03)

The Zacks Analyst Blog Highlights: Aegean Marine Petroleum Network, Danaos, Tsakos Energy Navigation, Horizon Pharma and ICON Public Limited
Zacks Equity Research - Zacks Investment Research - Wed Jan 13, 8:30AM CST
The Zacks Analyst Blog Highlights: Aegean Marine Petroleum Network, Danaos, Tsakos Energy Navigation, Horizon Pharma and ICON Public Limited
ANW: 6.32 (-0.01), HZNP: 19.38 (+0.49), TNP: 4.82 (-0.04), ICLR: 77.00 (+0.03), DAC: 4.32 (+0.09)

5 Smart PIIGS Stocks to Buy Now
Swarup Gupta - Zacks Investment Research - Tue Jan 12, 1:18PM CST
While stocks from Ireland offer a strong economic environment, picks from Greece are available at attractive valuations.
ANW: 6.32 (-0.01), HZNP: 19.38 (+0.49), TNP: 4.82 (-0.04), ICLR: 77.00 (+0.03), DAC: 4.32 (+0.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 48

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 117

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 56

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 79

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 382

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 59

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 421

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 87

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Voices: Chicago's Latina Trailblazers Unite

Updated Category News Views 156

Empowering Voices: Chicago's Latina Trailblazers Unite The Chicago History Museum is set to host a remarkable celebration of the book, Chicago Latina Trailblazers. This event recognizes the contributions of remarkable Latina leaders through compelling narratives of activism and community service. Event Overview On a significant date that marks a celebration of Latina...

Continue Reading
Mark Green to Keynote CyberScape Summit Focused on Cybersecurity

Updated Category News Views 132

Mark Green to Keynote CyberScape Summit U.S. House Homeland Security Committee Chairman Mark Green is set to showcase his insights as the keynote speaker for GovCIO Media & Research's CyberScape Summit. The event promises to be an essential gathering for those interested in advancing cybersecurity practices and policies within the government. Focus on Cybersecurity and...

Continue Reading
Brian D. Pieninck Takes Leadership Role at GuideWell

Updated Category News Views 539

Brian D. Pieninck Assumes Role as GuideWell President & CEO GuideWell Mutual Holding Corporation has recently made a significant executive decision by appointing Brian D. Pieninck as the new president and chief executive officer (CEO), effective October 1. Previously, Pieninck served as the president and CEO of CareFirst BlueCross BlueShield and was the Board Chair for...

Continue Reading
Calidi Biotherapeutics Unveils Promising CLD-401 Data at SITC

Updated Category News Views 175

Calidi Biotherapeutics Showcases CLD-401 at SITC Calidi Biotherapeutics, Inc. (NYSE: CLDI), a clinical-stage biotechnology firm, recently presented impactful new data regarding its lead therapeutic candidate CLD-401 during the Society for Immunotherapy of Cancer (SITC) Annual Meeting. This presentation highlighted the innovative capabilities of Calidi’s RedTail...

Continue Reading
Everlight Solar: Milwaukee's Top Pick for Eco Energy

Updated Category News Views 21

A High Wattage Win for Everlight Solar Milwaukee seems to have found its favorite solar squad, and it’s none other than Everlight Solar, folks. They’ve locked in the 2026 Milwaukee's Top Choice in the Solar Services Company category. Now, that’s a badge you wear with pride when it's handed out by the very community you serve. It's not every day you see a company...

Continue Reading